گیرنده‌های پیش‌سیناپسی و انتقال‌دهنده‌های عصبی ۲۰۱۳
Presynaptic Receptors and Neuronal Transporters 2013

1. Cover image

2. Title page

3. Table of Contents

4. ADVANCES IN THE BIOSCIENCES

5. Copyright

6. Preface

7. Chapter 1: Physiological and Pharmacological Relevance of Presynaptic Receptors in Neurotransmission

8. Chapter 2: Pre- and Postjunctional Muscarinic Receptors in the Guinea-pig Trachea

9. Chapter 3: Presynaptic α-autoadrenoceptors on Peripheral Noradrenergic Neurones of Newborn Rabbits and Dogs

10. Chapter 4: Cholinergic–Adrenergic Presynaptic Interactions in the Heart and Characterization of the Receptors Involved

11. Chapter 5: Structural Requirements for DA2 (peripheral) Dopamine Receptor Agonist Activity

12. Chapter 6: α2-adrenoceptor Modulation of Noradrenaline Release in Human and Rabbit Renal Arteries: Clonidine Acts as a Partial Agonist

13. Chapter 7: Effect of α2-adrenoceptor Antagonists on Norepinephrine Release and Inhibition of Insulin Secretion During Pancreatic Nerve Stimulation. Interactions at Pre- and Postsynaptic Sites

14. Chapter 8: Antagonist Activity of SL 84.0418 and Idazoxan at Pre and Postsynaptic α2-adrenoceptors

15. Chapter 9: Does the Distance Between Nerve Varicosities and Adrenoceptors Play Any Role in the Relative Contribution of ATP/Noradrenaline for Postjunctional Response?

16. Chapter 10: In vivo Presynaptic Interaction Between 5-HT and Adrenergic Antagonists on Noradrenergic Neurotransmission

17. Chapter 11: Activity of N-ethyl-nor-arecaidine Propargyl Ester and (R)-nipecotic Acid Ethyl Ester at Pre- and Postsynaptic Muscarinic Receptor Subtypes

18. Chapter 12: Effects of Neuromuscular Blocking Agents on Neuronal Nicotine Receptors of Motor Nerves: Blockade of Nicotinic Autofacilitation and Backfiring

19. Chapter 13: A Rapid in vitro Assay of the Histamine H3-receptor: Inhibition of Electrically Evoked Contractions of Guinea-pig Ileum Preparations

20. Chapter 14: Factors Influencing the Function of Presynaptic α2-adrenoceptors in Rat Brain

21. Chapter 15: Presynaptic Dopaminergic Autoreceptors as Targets for Drugs

22. Chapter 16: DOPA Itself Facilitates Noradrenaline Release via Presynaptic β-adrenoceptors in Rat Hypothalamic Slices — DOPA is Probably a Neuroactive Substance

23. Chapter 17: The Third Dopamine Receptor (D3) as an Autoreceptor

24. Chapter 18: Terminal Dopaminergic Autoreceptors are of Minor Importance for the Sedation Produced by DA Receptor Agonists in Rats

25. Chapter 19: Modulation of 5-HT Release by Presynaptic Inhibitory and Facilitatory 5-HT Receptors in Brain Slices

26. Chapter 20: Modulation of 5-hydroxytryptamine and Noradrenaline Release in the Brain and Retina via Presynaptic Heteroreceptors: Some New Aspects

27. Chapter 21: Autoreceptors and Heteroreceptors Evidenced by Histamine H3 Receptor Ligands

28. Chapter 22: Somato-dendritic 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus; Pharmacological and Functional Properties

29. Chapter 23: Autoreceptor-mediated Control of Serotonin Release in the Rat Brain in vivo

30. Chapter 24: Effects of α2-adrenoceptor Agonist and Antagonist on Spatial Memory in Rats

31. Chapter 25: Modulation of the Ca2+-evoked Release of Dopamine from Synaptosomes

32. Chapter 26: Evidence Against a Direct Link Between Serotonin Uptake Sites and Presynaptic Serotonin Autoreceptors

33. Chapter 27: A Comparison of Presynaptic Serotonin Autoreceptors in Rabbit, Rat and Guinea-pig Brain Cortex

34. Chapter 28: Serotonergic Modulation of the Release of [3H]GABA from Guinea-pig Hippocampal Synaptosomes

35. Chapter 29: Pre- and Postsynaptic Location of 5-HT3 Receptors in the Rat Spinal Cord

36. Chapter 30: Distribution of [3H]SCH 23390 Binding Sites in the Human Substantia Nigra

37. Chapter 31: Presynaptic Regulation of Dopamine Release from Synaptosomes of the Rat Striatum is Controlled by Different Types of Glutamate Receptors

38. Chapter 32: Microdialysis Studies of the Effects of Local Apomorphine Infusions on Dopamine Release in Rat Striatum

39. Chapter 33: Dopaminergic Hetero-regulation of Striatal μ-Opiate Receptors: Further Evidence for Their Postsynaptic Location

40. Chapter 34: Presynaptic Modulation of Striatal Dopamine Release by Enkephalins

41. Chapter 35: Modulation of Dopamine and Acetylcholine Release in the Rabbit Caudate Nucleus by Opioids: Receptor Type and Interaction with Autoreceptors

42. Chapter 36: Presynaptic Autoreceptors May Control the Release of Metenkephalin from the Rat Spinal Cord

43. Chapter 37: Involvement of NMDA Receptors in the Presynaptic Regulation of Dopamine Release in Striosome-and Matrix-enriched Areas of the Rat Striatum

44. Chapter 38: Inhibition of Synaptosomal Tyrosine Hydroxylase by Dopamine Autoreceptors: Role of Ca2+ and K+

45. Chapter 39: Dopaminergic Modulation of Striatal Sensory Responses

46. Chapter 40: Selective Presynaptic Dopamine Agonist Treatment of Schizophrenia with BHT-920

47. Chapter 41: Effects of the Antiparkinsonian Drugs Amantadine and Memantine on Striatal Neurotransmitter Release in vitro

48. Chapter 42: Transmitter Interactions in Striatum May Occur via Effects on High Affinity Transporters

49. Chapter 43: A Comparison of the Effect of Baclofen on Radiolabelled GABA and Noradrenaline Release in Rat Cortical Slices

50. Chapter 44: Effects of Chronic Treatment with Flunitrazepam on GABAA, Adenosine and Glutamate Receptor Plasticity in Rats

51. Chapter 45: Modulation of N-Methyl-D-Aspartate (NMDA)-stimulated Noradrenaline Release in Rat Brain Cortex by Presynaptic α2-adrenoceptors and Histamine H3 Receptors

52. Chapter 46: Noradrenaline Release in the Pig Retina and Its Histamine H3 Receptor-mediated Inhibition

53. Chapter 47: Structure and Function of the GABA Reuptake System

54. Chapter 48: Energizing the Vacuolar System of Eukaryotic Cells

55. Chapter 49: The Molecular Size of the Neuronal Noradrenaline Carrier

56. Chapter 50: Identification and Regulation of High-affinity-choline Transporter

57. Chapter 51: Ketanserin as a Ligand of the Vesicular Monoamine Transporter

58. Chapter 52: Dopamine Transporter — Cocaine Receptor: Characterization and Purification

59. Chapter 53: Characterization and Purification of the Serotonin Transporter Located at the Cytoplasmic Membrane of Human Platelets: A Three-step Strategy

60. Chapter 54: Molecular Characterization of the Neuronal Sodium-ion Coupled 5-hydroxytryptamine Transporter

61. Chapter 55: Kinetic Analyses of the Na+ and Cl−-Dependences of the Synaptosomal Specific Uptake of 3H Dopamine

62. Chapter 56: Localization of Dopamine Uptake Complex by BTCP on Rat Brain Sections and Dopaminergic Neurons in vitro

63. Chapter 57: In vivo Binding of [3H]GBR 12783 in Mouse Brain — Characteristics of the Labelling of Striatal Dopamine Uptake Sites

64. Chapter 58: [3H]GBR12935 Binds to Membrane from the Human Platelet

65. Chapter 59: Dopamine Transporter in Aging

66. Chapter 60: Sodium Dependent, High Affinity Choline Transport Expressed in Oocytes

67. Chapter 61: Comparison of the Effects of Vesamicol and of Cetiedil Analogues on Acetylcholine Release and Vesicular Acetylcholine Transport

68. Chapter 62: Dopamine Modulates [3H]BTCP (a Phencyclidine Derivative) Binding to the Dopamine Uptake Complex

69. Chapter 63: The Heterogeneous Labelling with 3H-noradrenaline of the Incubated Vas Deferens of the Rat

70. Chapter 64: Alterations in Platelet [3H]-Imipramine Binding, 5HT Uptake and Plasma α1-acid Glycoprotein Concentrations in Patients with Major Depression

71. Chapter 65: Ionic and Temperature Dependences of the 3H Dopamine Specific Uptake and 3H GBR 12783 or 3H Mazindol Specific Binding on the Dopamine Neuronal Carrier

72. Chapter 66: Dynamic Properties of Monoamine Storage Vesicles: Pharmacological and Physiological Implications

73. Chapter 67: GABA Uptake Inhibitors: Kinetics and Molecular Pharmacology

74. Chapter 68: Coexistence of More Than One Neurotransmitter Uptake System on the Same Nerve Terminal in the Brain

75. Chapter 69: Peptidergic Regulation of Striatal Dopamine Transporter Complex

76. Chapter 70: Different Interactions of Citalopram with the Prejunctional Effects of Serotonin in Peripheral Tissues

77. Chapter 71: Evolution of the Vesicular Monoamine Transporter During Ageing in the Rat Brain: a Quantitative Autoradiographic Study with 3H Dihydrotetrabenazine

78. Chapter 72: Influence of the Oxygen Disponibility on the Efficiency of the Neuronal Dopamine Uptake Complex

79. Chapter 73: Differences in Behavioural Responses Elicited by Dexamphetamine and the Pure Dopamine Uptake Inhibitor GBR 12783

80. Chapter 74: Protection of the Synaptosomal 5-HT Uptake System by a Ginkgo Biloba Extract (GBE 761)

81. Chapter 75: The Binding of Noradrenaline to the Substrate Recognition Site of the Neuronal Noradrenaline Carrier (Uptake1) Depends on Sodium and Chloride

82. Chapter 76: In vivo Distribution of Radiolabelled Citalopram in Brain as a Marker of 5-HT Uptake Sites for PET

83. Chapter 77: Relationship of [3H]Paroxetine Binding and 5-HT Recognition Sites on the Neuronal Serotonin Transporter

84. Chapter 78: Effects of Repeated Administration of Antidepressants on Serotonin Uptake Sites Measured Using [3H]Cyanoimipramine Autoradiography

85. Chapter 79: Rapid Changes in 3H-Imipramine Binding in Platelets of Depressed Patients After Amineptine Treatment

86. Chapter 80: Brain 5-HT Uptake Sites, Labelled with [3H]Paroxetine, in Depressed Suicides

87. Chapter 81: Pinoline, the Natural Ligand of Serotonin Transporter in Retina and Pineal Gland

88. Chapter 82: Differential Interaction of Phencyclidine (PCP) with the Dopamine Uptake Complex and the PCP Receptor in vivo

89. Chapter 83: The Uptake of the Amino Acid L-alanine on Its Inhibitory Presynaptic Effects in Rat Isolated Atria

90. Chapter 84: Role of Omega (BZD) Sites of the GABAA Receptor Macromolecular Complex in the Modulation of Serotonin Release

91. Chapter 85: Mechanisms of Inhibition of Transmitter Release by Adenosine Analogs

92. Chapter 86: Dependence of the A1-adenosine Receptor-mediated Inhibition of [3H]Noradrenaline Release in Hippocampus on the Stimulation Conditions

93. Chapter 87: Modulation of [3H]-serotonin Release in Rat Spinal Cord Synaptosomes via Dihydropyridine-sensitive Calcium Channels and Protein Kinase C

94. Chapter 88: G-proteins and Prejunctional α-adrenoceptors

95. Chapter 89: Opioid Inhibition of Oxytocin Release, but not Autoinhibition of Dopamine Release May Involve Activation of Potassium (K+) Channels

96. Chapter 90: 3,4-diaminopyridine-evoked Noradrenaline Release in Hippocampal Slices: Further Properties and Involvement of Adenylate Cyclase

97. Chapter 91: Interneuronal Cyclic GMP and ‘EDRF-like Substance’ Modulate Norepinephrine Release from Peripheral Sympathetic Nerves

98. Chapter 92: Modulatory Role of Neuropeptide Y and Peptide YY at the NMDA Receptor Complex

99. Chapter 93: Prejunctional Neuropeptide Y Receptors Are Linked to a G-protein: a Study with N-Ethylmaleimide and Pertussis Toxin

100. Chapter 94: Protein Kinase C and Modulation of Neurotransmission: Studies With Protein Kinase Inhibitors

101. Chapter 95: Intrasynaptosomal Protein Phosphorylation and Its Inhibition by Plasma Membrane Oxidoreductases

102. Chapter 96: Functional and Regulatory Properties of Presynaptic Autoreceptors of the 5-HT1A Subtype on Dorsal Raphe Neurons in Brain Stem Slices

103. Chapter 97: Do Schwann Cells Play a Role in ‘Upstream’ Regulation of the Release Probability in Sympathetic Nerve Varicosities?

104. Chapter 98: Changes in α2 Presynaptic Receptor Sensitivity During Production of Dependence to Morphine in Conscious Rats

105. Chapter 99: Role of Presynaptic α2 Heteroreceptors in Nonsynaptic Modulation of Transmitter Release

106. Chapter 100: Autoregulation of Catecholamine Release at Central and Sympathetic Nerve Terminals: Common Features

107. Chapter 101: Autoreceptor Mediated Changes in Dopaminergic Terminal Excitability in vivo

108. Chapter 102: Prejunctional Autoreceptors in Mouse vas deferens

109. Chapter 103: SK&F 104078 Identifies Subtypes of Prejunctional α2-adrenoceptors in the Rat vas deferens

110. Chapter 104: Clonidine Inhibition of Norepinephrine Release from Normal and Morphine-Tolerant Guinea Pig Cortical Slices

111. Chapter 105: Human Caki-1 Cells Are the First Clonal Cell Line Known to Possess the Extraneuronal Transport Mechanism for Noradrenaline (Uptake2)

112. Chapter 106: Inhibition of NA Uptake by (+)-oxaprotiline Inhibits Sympathetic Nerve Activity

113. Chapter 107: Autoregulation of Evoked Noradrenaline Release at the Surface of the Isolated Rat Tail Artery Studied by Electrochemistry

114. Chapter 108: Autoregulation of Evoked Noradrenaline Release in the Rat Hypothalamic Paraventricular Nucleus Studied in vivo by Electrochemistry

115. Chapter 109: Clonidine Early in Life: Effect on Brain Morphofunctional Disturbances Induced by Neonatal Malnutrition in the Rat

116. Chapter 110: μ and κ Agonists Inhibit Carbachol-evoked Release of Catecholamines and [Met]enkephalin from ex situ Perfused Dog Adrenals

117. Chapter 111: Electrophysiological Evidences for the Preferential Location of D2 Autoreceptors on Dendrites of DA Neurons in the Rat Substantia Nigra

118. Chapter 112: Increase of Postsynaptic Dopaminergic Transmission by Presynaptic Actions of Cocaine

119. Chapter 113: Autoregulation of Evoked Dopamine Release in the Rat at Central Terminal Sites Studied in vivo by Electrochemistry

120. Chapter 114: Combined Effect of (–)-Vesamicol and (+)-Tubocurarine on Endplate Current Amplitude in Rat Skeletal Muscle at High Frequencies of Nerve Stimulation

121. Chapter 115: Effect of (–)-Vesamicol on Miniature Endplate Current and Endplate Current Amplitudes in Rat Skeletal Muscle

122. Subject Index